Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-025880
Filing Date
2024-11-01
Accepted
2024-11-01 13:25:51
Documents
1
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 form4-11012024_051148.html 4  
1 form4-11012024_051148.xml 4 5956
  Complete submission text file 0001415889-24-025880.txt   7726
Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Leheny A. Rachel (Reporting) CIK: 0001484729 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39538 | Film No.: 241418283

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Issuer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)